While, all-trans retinoic acid (ATRA), the active metabolite of vitamin A and the downstream bio-product of RETSAT, has recently been used to inhibit and degrade Pin1, leading to reduced APL and triple negative breast cancer growth (Moise et al., 2004; Wei et al., 2015). The gene discussed is PIN1; the disease is acute promyelocytic leukemia.